Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATIE Schizophrenia Trial
NCT00014001Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Dec 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olanzapine, quetiapine, risperidone, ziprasidone, Perphenazine and 2 more in schizophrenia (5 arms), sponsored by National Institute of Mental Health. Started Dec 2000; status: completed.
02
Drugs
olanzapinequetiapinerisperidoneziprasidonePerphenazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00014001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014001.